Highlights of the Resources Area for IATDMCT Members

This month we highlight the Member’s only Resources Area which offers content from meetings, including congresses and regional meetings, as well as content proposed by the diverse scientific committees. These are grouped by multimedia type. In this post we share the content available to date, and invite members to continue contributing.


Contact the Communications Committee for further information.


If you would like to share your thoughts about the Resources area Tweet to IATDMCT, post in our LinkedIn group or comment on our Facebook page.


Members can find the following recorded audio:

  • Salt Lake City 2013 Congress
    • Bio-Nano-Chip Technologies for POC Testing of Drugs and Metabolites, John McDevitt
    • Pharmacogenomics and Personalized Cancer Treatment, William Evans
    • Human Genomics a Decade after the Human Genome Project, Eric Green
    • The Science Needed to Run an Olympic Laboratory: Experiences from the London 2012 Games, David Cowan

Taped video presentations, among them:

  • ISD Everolimus Consensus Regional Meeting, Stuttgart 2014
    • Clinical Pharmacology of Everolimus with focus on implication on Therapeutic Drug Monitoring, Eliane M Billaud
    • Pharmacogenetics of Everolimus, Pierre Marquet, Nicolas Picard
    • Pharmacodynamics and specific immunological aspects of the therapy with Everolimus, Eberhard Wieland
    • Practice of TDM of Everolimus: An Overview, Dennis A. Hesselink
    • Analytical Aspects of the Determination of Everolimus Concentrations, David W. Holt
  • Rotterdam 2015 Congress
    • A Survey on Laboratory Practice Around the World, Uwe Christians
    • Problems in the Treatment of Infectious Diseases and the Need for Individualization, Roger Brüggemann
    • PET-imaging in Drug Development, Adriaan Lammertsma
    • When and How to Treat Paracetamol Overdoses, Nick Bateman

Power Point slides, shared in pdf format, including:

  • Rotterdam 2015 Congress
    • Consensus Document on TDM for Everolimus, Maria Shipkova, Dennis A. Hessilink
  • Salt Lake City 2013 Congress, Pre-Congress meeting
    • 100 Years of Antiepileptic Drugs: The Role of TDM in Optimizing Patient Care, Philip N. Patsalos
    • Therapeutic Drug Monitoring (TDM) of New Antiepileptic Drugs Undergoing Development, Dan Kaufmann
    • Alternative Approaches to TDM of AEDs, David J. Berry
    • AED TDM in Women of Child Bearing Potential and in Pregnancy, Page B. Pennell
    • AED Polytherapy and Concurrent Pathologies: The Role of Therapeutic Drug Monitoring, Philip N. Patsalos
    • AED TDM in the Elderly and the Frail, Ilo Leppik
    • Modern Day Analysis of AEDs, William Clarke
    • TDM of Newly Licensed AEDs and the Future of AED TDM, Svein I. Johannessen
  • Biomarkers of Immunosuppression Symposium, Barcelona 2014 Auspices
    • Biomarkers Monitoring Requirement in Clinical Transplantation: State of the Art, Mercè Brunet
    • Early Predictive Biomarkers of the Risk of Rejection in Clinical Transplantation: Patient Stratification and Immunosuppression Election, Mercè Brunet, Eberhard Weiland
    • T Cell Alloreactivity Measurement, Olga Millán
    • T Cell Surface Antigens and Soluble CD30, Eberhard Wieland
    • IMPDH Activity: Association with MPA Personal Response and Clinical Outcome, Klemens Budde
    • Calcineurin Inhibitors: The Role of NFAT-Residual Gene Expression, Claudia Sommerer
    • Impact of Immunosuppressive Drugs on Immune System Effector/Regulatory Response, Marcos López-Hoyos
    • The Role of Metabolizing Enzyme Pharmacogenetics in the Disposition and Response to Calcineurin Inhibitors, Dennis Hesselink
    • Proteomics – Metabolomics: Impact of Immunosuppressive Drugs in Graft Clinical Outcome, Uwe Christians
    • Biomarkers of Renal Graft Injuries: results from BIOMARGIN study, Pierre Marquet
    • Graft-derived cfDNA as Biomarker of Graft Iintegrity in Transplant Recipients: A Review, Michael Oellerich
    • mTOR Monitoring: Target Concentrations when Combined with Tacrolimus, Teun van Gelder
    • PK PG Modelling for Tacrolimus in Kidney Transplantation, Stein Bergan

Practice guidelines published in our peer reviewed journal, Therapeutic Drug Monitoring:

  • Therapeutic Drug Monitoring of Everolimus: A Consensus Report (2016)
  • Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation (2016)
  • Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations: Recommendations of the IATDMCT Immunosuppressive Drugs Scientific Committee (2016)

Case Reports
Case Reports reflect the commitment of the Clinical Toxicology/Drugs of Abuse Committee, who have been published yearly in the Compass newsletter:

  • A Severe Case of Methyl Ethyl Ketone Peroxide Intoxication, Successfully Treated with N-Acetylcysteine and Haemodialysis, C.C.G. van Enckevort, D.J. Touw and L.J. Vleming (2015)
  • Lessons Learnt at the Clinic: Laboratory Monitoring of Rivaroxaban, Hemamalini Ketha, Loralie Langman (2014)
  • Doubtful Poisoning: Two Cases of Self-Diagnosis, Vanessa Steenkamp (2013)

Groups summaries, reviews and interviews:

  • Clinical Toxicology/Drugs of Abuse Committee groups summaries and reviews as published in the Compass
    • Alcohol and Chronic Diseases, Manuela Neumann
    • Personalized/Precision/Predictive Medicine and Personalized Justice: A President’s View, Steven Wong
    • Nicotine Metabolite Testing, Heather Signorelli, Kamisha Johnson-Davis, and Gwendolyn McMillin
    • HANGOVER – Post Drinking Effects of Alcohol: Adventure and Misadventure, Manuela Neumann
    • Liquid Chromatography Tandem Mass Spectrometry Assay for 20 Antiretrovirals in Meconium, Sarah Himes, Marilyn Huestis
    • Alcohol Interactions with Drug of Use: A Therapeutic Misadventure, Manuela Neumann
    • Metabolism and Toxicology of 3,4-Methylenedioxymethampetamine (MDMA), Andrea Schwaninger, Hans Maurer
    • Analytical Methods for the Determination of Gamma-Hydroxy Butyrate and its Analogs, André Scholer
    • Toxicology of Gamma-Hydroxy Butyrate, Olaf Drummer, Dimitri Gerostamoulos
  • Interviews performed by Eberhard Wieland following the Salt Lake City 2013 Congress
    • Michael Oellerich
    • Philip Patsalos
    • Dave Berry


The content of the IATDMCT Blog does not necessarily have the endorsement of the Association.
Communications Committee